To determine the prognostic impact of FAM83D expression in breast cancer, we categorized breast cancer patients into three groups based on FAM83D mRNA expression levels (low=bottom tertile, intermediate=middle tertile, and high=top tertile). Here, SACK1D is linked to breast carcinoma.